@article{ART002719610},
author={Faiza Khatoon and Qamar Uddin and Arzeena Jabeen and Mohd Azahar and Md Aftab Alam and Abdul Munim},
title={Management of Psoriasis through Unani Medicine: a Case Study},
journal={CELLMED},
issn={3022-6805},
year={2021},
volume={11},
number={2},
pages={11-11},
doi={10.5667/CellMed.2021.0011}
TY - JOUR
AU - Faiza Khatoon
AU - Qamar Uddin
AU - Arzeena Jabeen
AU - Mohd Azahar
AU - Md Aftab Alam
AU - Abdul Munim
TI - Management of Psoriasis through Unani Medicine: a Case Study
JO - CELLMED
PY - 2021
VL - 11
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 11
EP - 11
SN - 3022-6805
AB - Psoriasis is a chronic inflammatory skin disease clinically characterized by erythematous, sharply demarcated papules and rounded plaques covered by silvery white micaceous scales. It affects about 1-3% of the world’s population. Although considerable advances have been made in the management of psoriasis in recent years, the disease remains incurable. Current treatment does not affect disease activity, and relapse occurs quickly after cessation of treatment. Moreover, topical and systemic conventional therapies used in the management of psoriasis are associated with adverse effects. In Unani system of medicine, psoriasis is known as Taqashshur al-Jild, which is caused by predominance of black bile and characterised by scaling of skin. Various topical as well as systemic Unani formulations are effectively used in the management of psoriasis. This case study was aimed to evaluate the efficacy of Unani formulations, Itrīfal Shāhtra and Marham Ḥinā in the management of psoriasis. A 49-year-old male patient presenting with psoriasis came to the OPD of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. Treatment was given to the patient for a period of 12 weeks. PASI score was significantly reduced from 40.5 at baseline to 2.2 after treatment. Unani formulations were found safe and effective in the management of Psoriasis as assessed by validated scales.
KW - Psoriasis;Taqashshur al-Jild;Unani;Itrīfal Shāhtra;Marham Ḥinā;PASI
DO - 10.5667/CellMed.2021.0011
ER -
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam and Abdul Munim. (2021). Management of Psoriasis through Unani Medicine: a Case Study. CELLMED, 11(2), 11-11.
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam and Abdul Munim. 2021, "Management of Psoriasis through Unani Medicine: a Case Study", CELLMED, vol.11, no.2 pp.11-11. Available from: doi:10.5667/CellMed.2021.0011
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam, Abdul Munim "Management of Psoriasis through Unani Medicine: a Case Study" CELLMED 11.2 pp.11-11 (2021) : 11.
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam, Abdul Munim. Management of Psoriasis through Unani Medicine: a Case Study. 2021; 11(2), 11-11. Available from: doi:10.5667/CellMed.2021.0011
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam and Abdul Munim. "Management of Psoriasis through Unani Medicine: a Case Study" CELLMED 11, no.2 (2021) : 11-11.doi: 10.5667/CellMed.2021.0011
Faiza Khatoon; Qamar Uddin; Arzeena Jabeen; Mohd Azahar; Md Aftab Alam; Abdul Munim. Management of Psoriasis through Unani Medicine: a Case Study. CELLMED, 11(2), 11-11. doi: 10.5667/CellMed.2021.0011
Faiza Khatoon; Qamar Uddin; Arzeena Jabeen; Mohd Azahar; Md Aftab Alam; Abdul Munim. Management of Psoriasis through Unani Medicine: a Case Study. CELLMED. 2021; 11(2) 11-11. doi: 10.5667/CellMed.2021.0011
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam, Abdul Munim. Management of Psoriasis through Unani Medicine: a Case Study. 2021; 11(2), 11-11. Available from: doi:10.5667/CellMed.2021.0011
Faiza Khatoon, Qamar Uddin, Arzeena Jabeen, Mohd Azahar, Md Aftab Alam and Abdul Munim. "Management of Psoriasis through Unani Medicine: a Case Study" CELLMED 11, no.2 (2021) : 11-11.doi: 10.5667/CellMed.2021.0011
